Trial intelligence / Profile preview

GH Replacement Therapy After Bariatric Surgery in Severe Obesity

NCT00553852Phase 3Completed

Sponsor
University of Naples Federico II
Start
Jul 2007
Primary completion
Jan 2008
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of somatropin in obesity, growth hormone deficiency (GHD), sponsored by University of Naples Federico II. Started Jul 2007; status: completed.

02

Drugs

somatropin
03

Conditions

obesitygrowth hormone deficiency (GHD)

Beyond the preview

Go deeper on NCT00553852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00553852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call